opc 12759 has been researched along with devazepide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahn, W; Case, RM; Kim, H; Kim, KH; Lee, MG; Lee, SI; Moon, SJ; Seo, JT | 1 |
2 other study(ies) available for opc 12759 and devazepide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A novel effect of rebamipide: generation of [Ca(2+)](i) oscillations through activation of CCK(1) receptors in rat pancreatic acinar cells.
Topics: Alanine; Animals; Anti-Ulcer Agents; Atropine; Benzodiazepinones; Calcium; Devazepide; Fluorescent Dyes; Fura-2; In Vitro Techniques; Male; Muscarinic Antagonists; Pancreas; Phenylurea Compounds; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin | 2000 |